OLGA MARÍA
CRUZ LÓPEZ
PROFESORA TITULAR DE UNIVERSIDAD
Publicaciones en las que colabora con OLGA MARÍA CRUZ LÓPEZ (9)
2023
-
N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect
European Journal of Medicinal Chemistry, Vol. 258
2022
-
Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles
Pharmaceutics, Vol. 14, Núm. 4
2019
-
Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity
ACS Omega, Vol. 4, Núm. 25, pp. 21620-21626
2010
-
Evaluación de la implantación de un nuevo recurso didáctico -diapositivas dinámicas- en la asignatura de Química Orgánica en la Licenciatura de Farmacia
Ars pharmaceutica, Vol. 51, Núm. 1, pp. 191-200
2008
-
Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines
Current Medicinal Chemistry, Vol. 15, Núm. 25, pp. 2614-2631
-
From 5-fluorouracil acyclonucleosides to benzo-fused six- and seven-membered rings linked to pyrimidine and purine bases: The shift from differentiating anticancer agents to apoptotic inducers
Expert Opinion on Drug Discovery, Vol. 3, Núm. 10, pp. 1223-1235
-
Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin- 3-ylmethyl)-9H-purines
ChemMedChem, Vol. 3, Núm. 1, pp. 127-135
2005
-
1H and 13C spectral assignment of symmetrical bis[(4-aminosubstituted)quinolinium] derivatives
Magnetic Resonance in Chemistry, Vol. 43, Núm. 12, pp. 1066-1071
-
Symmetrical bis-quinolinium compounds: New human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line
Journal of Medicinal Chemistry, Vol. 48, Núm. 9, pp. 3354-3363